Table 3.

CELx HSF test summary results of clinically HER2-negative patient tumor samples

Characteristic	No. of patients	No. abnormal signaling patients	% of category
Total patients	114	27	24
Stage
I	23	5	22
II	62	11	18
III	25	9	36
IV	4	2	50
Estrogen receptor status
ER+	96	24	25
ER−	18	3	17